Back to results
US 2020/0390856 A1Published application
Methods of treating autoimmune disease
AssigneeUTI Limited Partnership
InventorPedro SANTAMARIA
Life of this patent
Estimating the term…
Abstract
Described herein are compositions and methods useful for treating autoimmune diseases and inflammatory disorders. The compositions and methods utilize ubiquitous, non-tissue specific antigens associated with major histocompatibility complexes (MHCs) and coupled to a nanoparticle core to induce regulatory T cells and regulatory B cells.
Claims104
A composition for use in treating an autoimmune or inflammatory disease, the composition comprising:
- a) a plurality of antigen-major histocompatibility complexes (antigen-MHCs), each antigen-MHC of the plurality comprising a ubiquitous autoantigen associated with a binding groove of an MHC molecule, wherein the ubiquitous autoantigen is not a tissue specific antigen of the autoimmune or inflammatory disease;
- and
- b) a nanoparticle core possessing a diameter of between 1 and about 100 nanometers;
- wherein the antigen-MHCs are coupled to the nanoparticle core or a biocompatible layer surrounding the nanoparticle core.
1 more element
A method of treating an autoimmune or inflammatory disease in an individual comprising administering to an individual a composition comprising:
- a) a plurality of antigen-major histocompatibility complexes (antigen-MHCs), each antigen-MHC of the plurality comprising a ubiquitous autoantigen associated with a binding groove of an MHC molecule, wherein the ubiquitous autoantigen is not a tissue specific antigen of the autoimmune or inflammatory disease;
- and
- b) a nanoparticle core possessing a diameter of between 1 and about 100 nanometers;
- wherein the antigen-MHCs are coupled to the nanoparticle core or a biocompatible layer surrounding the nanoparticle core.
1 more element
Dependencies are inferred from the claim text.